IP Watch: EU Eyes Revamp Of Policy To Speed Drug Approvals In Developing countries

Article 58, a process introduced by the European Commission to help speed up the time low and middle-income countries take to approve new drugs, could be in for a massive overhaul. A revamp has been proposed because it is underused – just a handful of products have gone through the Article 58 process since its … Continue reading IP Watch: EU Eyes Revamp Of Policy To Speed Drug Approvals In Developing countries